Last updated on November 2017

A randomized,double-blind, placebo-controlled phase III study of regorafenib plus best supportive care versus placebo plus best supportive care for subjects with metastatic and/or unresectable gastrointestinal stromal tumors (GIST) whose disease has progressed despite prior treatment with at least imatinib and sunitinib


Brief description of study

A randomized,double-blind, placebo-controlled phase III study of regorafenib plus best supportive care versus placebo plus best supportive care for subjects with metastatic and/or unresectable gastrointestinal stromal tumors (GIST) whose disease has progressed despite prior treatment with at least imatinib and sunitinib

Detailed Study Description

A randomized, double-blind, placebo-controlled phase III study of regorafenib plus best supportive care versus placebo plus best supportive care for subjects with metastatic and/or unresectable gastrointestinal stromal tumors (GIST) whose disease has progressed despite prior treatment with at least imatinib and sunitinib.

The study is composed of 3 periods: A Screening Period, a Treatment Period, and a Survival Follow up Period.

Subjects randomized to be treated with regorafenib will receive 160 mg po od for 3 weeks of every 4 week (28 day) cycle (ie, 3 weeks on/1 week off). In addition subjects will receive best supportive care which excludes any disease specific anti cancer therapy such as any kinase inhibitor, chemotherapy, radiation therapy, or surgery.

Tumor assessment will be every 4 weeks for the first 3 months, every 6 weeks for the next 3 months (through month 6), and every 8 weeks until the end of treatment, or more frequently if clinically indicated. Tumor assessments include CT or MRI and will be performed until tumor progression is seen in a central radiology review.

Subjects receiving placebo who experience disease progression may be offered active treatment.

Subjects who experience progression during regorafenib treatment may continue open label treatment.

All subjects will enter the Survival Follow-up Period upon discontinuation of randomized study treatment.

For Study Locations, Click Here

Clinical Study Identifier: TX15695

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Research Center

Research Center
Additional Locations, XX Austria
  Connect »

Research Center

Research Center
Additional Locations, XX Belgium
  Connect »

Research Center

Research Center
Additional Locations, XX Canada
  Connect »

Research Center

Research Center
Additional Locations, XX China
  Connect »

Research Center

Research Center
Additional Locations, XX Finland
  Connect »

Research Center

Research Center
Additional Locations, XX France
  Connect »

Research Center

Research Center
Additional Locations, XX Germany
  Connect »

Research Center

Research Center
Additional Locations, XX Israel
  Connect »

Research Center

Research Center
Additional Locations, XX Italy
  Connect »

Research Center

Research Center
Additional Locations, XX Japan
  Connect »

Research Center

Research Center
Additional Locations, XX Republic of Korea
  Connect »

Research Center

Research Center
Additional Locations, XX Netherlands
  Connect »

Research Center

Research Center
Additional Locations, XX Poland
  Connect »

Research Center

Research Center
Additional Locations, XX Singapore
  Connect »

Research Center

Research Center
Additional Locations, XX Spain
  Connect »

Research Center

Research Center
Additional Locations, XX Switzerland
  Connect »

Research Center

Research Center
Additional Locations, XX United Kingdom
  Connect »

Research Center

Research Center
Additional Locations, AL USA
  Connect »

Research Center

Research Center
Additional Locations, AZ USA
  Connect »

Research Center

Research Center
Additional Locations, CA USA
  Connect »

Research Center

Research Center
Additional Locations, CO USA
  Connect »

Research Center

Research Center
Additional Locations, FL USA
  Connect »

Research CenterResearch Center

Research CenterResearch Center
Additional Locations, GA USA
  Connect »

Research Center

Research Center
Additional Locations, IL USA
  Connect »

Research Center

Research Center
Additional Locations, MD USA
  Connect »

Research Center

Research Center
Additional Locations, MA USA
  Connect »

Research Center

Research Center
Additional Locations, MN USA
  Connect »

Research Center

Research Center
Additional Locations, NY USA
  Connect »

Research Center

Research Center
Additional Locations, OR USA
  Connect »

Research Center

Research Center
Additional Locations, PA USA
  Connect »

Research Center

Research Center
Additional Locations, TX USA
  Connect »

Research Center

Research Center
Additional Locations, UT USA
  Connect »

Research Center

Research Center
Additional Locations, WA USA
  Connect »